The new offering represents part of the company's responses to growing demands for a wide range ofgenomic and sequencing services in the nation's healthcare and life science space, consolidating its ...
Consensys initiates Linea’s governance decentralization via the Linea Association, targeting community-led control by 2025. Linea’s phased transition includes sequencer decentralization and ...
Frost & Sullivan’s independent team of experts selected QSI for this honor based on the company’s pioneering technology and commitment to advancing proteomics. The Platinum instrument addresses a ...
Singular Genomics Systems, Inc. (Nasdaq: OMIC), a company leveraging novel next-generation sequencing (NGS) and spatial multiomics technologies to empower researchers and clinicians, today highlighted ...